← brief for 2026-09-10 · Slowing decline

Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry.

Article C Peer reviewed Observational

Key takeaways

Doctors in Turkey reviewed records from the FINE-TURK registry to see how the drug finerenone performed in people who have type 2 diabetes, kidney disease and heart failure all at once. Finerenone is known to protect the heart and kidneys in diabetes with kidney disease, but people with heart failure were barely studied before. The report describes who these patients were and what happened to their kidneys over a short follow-up. It is a look-back at real-world records, so it shows patterns, not proof that the drug caused the results.

Who did this work

Yadigar S · Akgür S · Güvenç TS · Sezen M · Özcan B · Yıldırım Ayaz E · Doğantekin B · Atay İ · Değer SM · Demir M · Koyuncu S · Yılmaz Ü

Source

Article · PubMed, the drug frontier · 2026 Sep 10
https://pubmed.ncbi.nlm.nih.gov/42720721/